Home » Topics » BioWorld Science

BioWorld Science
RSS

MM-3122, a novel TMPRSS2 inhibitor with antiviral activity against SARS-CoV-2 and MERS-CoV

Nov. 5, 2021

Parkinson's disease model confirms metabolic, contests anatomic tenets

Nov. 5, 2021

Japanese researchers disclose new SPR inhibitors

Nov. 5, 2021

Teijin Pharma and Amgen synthesize TRPC6 antagonists

Nov. 5, 2021

BPN-15477 corrects splicing defect caused by the c.2988G>A variant in CFTR

Nov. 5, 2021

Qilu Pharmaceutical presents EGFR inhibitors for lung cancer

Nov. 5, 2021

Beijing Scitech-Mq Pharmaceuticals divulges EGFR and/or HER2 inhibitors

Nov. 5, 2021

Chengdu Baiyu Pharmaceutical patents DNA-PK inhibitors

Nov. 5, 2021

ELD-607 reduces pulmonary inflammation and lung damage in vivo

Nov. 5, 2021

SP-101 administration restores airway epithelial function in cystic fibrosis

Nov. 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...